| Autor: |
Naoko Yano, Pin Fee Chong, Kenji K. Kojima, Tomoichiro Miyoshi, Ahmad Luqman- Fatah, Yu Kimura, Kengo Kora, Taisei Kayaki, Kanako Maizuru, Takahiro Hayash, Atsushi Yokoyama, Masahiko Ajiro, Masatoshi Hagiwara, Teruyuki Kondo, Ryutaro Kira, Junko Takita, Takeshi Yoshida |
| Zdroj: |
Journal of Medical Genetics; Oct2024, Vol. 61 Issue 10, p950-958, 9p |
| Abstrakt: |
Background SINE- VNTR- Alu (SVA) retrotransposons move from one genomic location to another in a 'copyand- paste' manner. They continue to move actively and cause monogenic diseases through various mechanisms. Currently, disease- causing SVA retrotransposons are classified into human- specific young SVA_E or SVA_F subfamilies. In this study, we identified an evolutionarily old SVA_D retrotransposon as a novel cause of occipital horn syndrome (OHS). OHS is an X- linked, copper metabolism disorder caused by dysfunction of the copper transporter, ATP7A. Methods We investigated a 16- year- old boy with OHS whose pathogenic variant could not be detected via routine molecular genetic analyses. Results A 2.8 kb insertion was detected deep within the intron of the patient's ATP7A gene. This insertion caused aberrant mRNA splicing activated by a new donor splice site located within it. Long- read circular consensus sequencing enabled us to accurately read the entire insertion sequence, which contained highly repetitive and GC- rich segments. Consequently, the insertion was identified as an SVA_D retrotransposon. Antisense oligonucleotides (AOs) targeting the new splice site restored the expression of normal transcripts and functional ATP7A proteins. AO treatment alleviated excessive accumulation of copper in patient fibroblasts in a dose- dependent manner. Pedigree analysis revealed that the retrotransposon had moved into the OHScausing position two generations ago. Conclusion This is the first report of a human monogenic disease caused by the SVA_D retrotransposon. The fact that the evolutionarily old SVA_D is still actively transposed, leading to increased copy numbers may make a notable impact on rare genetic disease research. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
